India  

Cipla

Indian multinational pharmaceutical company

Cipla    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Cipla: Indian multinational pharmaceutical company
Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai. Cipla primarily develops medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, and other medical conditions.

0
shares
ShareTweetSavePostSend
 

You Might Like


Cipla JV with Manipal subsidiary and Kemwell Biopharma to develop cell therapy


IndiaTimes - Published

Cipla launches real-time Covid-19 RT-PCR test kit, know details

The kit is validated by the Indian Council of Medical Research (ICMR) and is much more advanced than other RT PCR tests.
DNA - Published

In a first, 5 Indian pharma majors ally for Covid drug trials

In a first, five Indian pharma majors have joined hands to conduct phase-III clinical trials of investigational anti-viral drug Molnupiravir on mild Covid-19 patients. The companies include Dr Reddy's..
IndiaTimes - Published

DCGI gives emergency use nod to Moderna’s vaccine

Indian pharma major Cipla will “facilitate” the import of Covid vaccines donated by US biotech major Moderna, possibly in the near future, under licence for restricted use by India’s drug..
IndiaTimes - Published

Cipla gets DCGI nod to import Moderna's COVID-19 vaccine

In a boost to India's fight against coronavirus, the Drug Controller General of India (DCGI) has approved the emergency use of Moderna Covid-19 vaccine in India.
DNA - Published

Cipla gets DCGI nod to import Moderna's Covid vaccine for restricted emergency use in India: Sources

India's drug regulator DCGI has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna's Covid-19 vaccine for restricted emergency use in the country, official sources said..
IndiaTimes - Published

COVID-19: Big relief for foreign vaccine makers as DCGI exempts post-approval bridging trials

Cipla, which has been looking to commit USD 1 billion into bringing Moderna's single-dose mRNA booster vaccine to India, also requested an exemption.
DNA - Published

Moderna's single-dose Covid-19 vaccine in India likely next year; Pfizer ready with 5 crore doses for 2021

Moderna is expecting to launch a single-dose Covid-19 vaccine in India next year and is in talks with Cipla among other Indian firms, while another US giant Pfizer is ready to offer 5 crore shots in..
IndiaTimes - Published

Cipla introduces RT-PCR test kit 'ViraGen' in Indian market: All you need to know

ViraGen is Cipla's third offering in the Covid-19 testing segment. Cipla already has partnerships for antibody detection kit and antigen test kits.
DNA - Published

Roche, Cipla launch antibody cocktail Casirivimab and Imdevimab in India: Know price, function, benefits

The antibody cocktail is targeted at mild-to-moderate coronavirus patients above 12 years of age or older and at least weighing 40 kg.
DNA - Published

Companies set to double Remdesivir output

Even as the Centre announced a slew of measures to improve access of Covid-19 therapy, Remdesivir, major players including Zydus Cadila, Cipla, Mylan and Dr Reddy’s are ramping up production, which..
IndiaTimes - Published